General Information of Drug (ID: DMMSHX4)

Drug Name
US9623028, Compound 79 Drug Info
Synonyms SCHEMBL15882853; CHEMBL4093026; US9623028, Compound 79; BDBM317465; 4-(4-(cyclopentyloxy)-5-(4- (methylcarbamoyl)phenyl)-7H- pyrrolo[2,3-d]pyrimidin-2- ylamino)-3-methoxy-N- methylbenzamide
Cross-matching ID
PubChem CID
77846902
TTD Drug ID
DMMSHX4

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9623028, Compound 101 DM6F7M2 N. A. N. A. Patented [1]
CQ7 DMXP073 N. A. N. A. Patented [1]
PMID22136433C20 DMI8217 Discovery agent N.A. Investigative [2]
STO609 DMZSOG2 Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calmodulin-dependent kinase II (CAMKK2) TTV298Y KKCC2_HUMAN Inhibitor [1]

References

1 Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof. US9623028.
2 7,8-dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. J Med Chem. 2012 Jan 12;55(1):403-13.
3 STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002 May 3;277(18):15813-8.